The analysis of the co-expression of LAG-3, TIM-3 and PD-1 in NKT-like cells in AML patients showed a statistically significant increase of the percentage of NKT-like cells that did not express any of these three inhibitory receptors (LAG-3− TIM-3− PD-1−). This evidence concerns the gene LAG3 and acute myeloid leukemia.